In vitro and in vivo effects of rifabutin alone or combined with atovaquone against Toxoplasma gondii.
The efficacy of rifabutin (RIFA) alone or in combination with atovaquone (ATO) was examined in vitro and in a murine model of acute toxoplasmosis. In vitro studies were performed with MRC5 fibroblast tissue cultures, with quantification of Toxoplasma growth by enzyme-linked immunosorbent assay. For...
Na minha lista:
| Publicado no: | Antimicrob Agents Chemother |
|---|---|
| Principais autores: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
American Society for Microbiology (ASM)
1996
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC163465/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/8878573/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.40.9.2015 |
| Tags: |
Sem tags, seja o primeiro a adicionar uma tag!
|